Highest-materiality recent filing
DXP Q2 2026 sales rise 15.6% to $576.5M; GAAP EPS $1.76; FCF $29.8M
Sales of $576.5M, up 15.6% YoY; GAAP diluted EPS of $1.76.
DXP Enterprises upsizes ABL revolver to $225M, extends maturity to 2031
ABL facility increased from $185M to $225M; maturity extended to July 2, 2031.
DXP Q1 sales $521.7M (+9.5% YoY), EPS $1.22, Adjusted EBITDA $57.8M
Sales increased 9.5% year-over-year to $521.7 million for Q1 2026.
DXP Enterprises reports fiscal 2025 sales $2B, up 11.9%; net income $88.7M, EPS $5.37
Fiscal 2025 sales $2.0B, up 11.9% YoY; GAAP diluted EPS $5.37.
DXP refinances debt, adds $205M incremental term loan, totals $848M at SOFR+3.25%
Entered Term Loan Amendment on Dec 16, 2025; $205M incremental term loan brings total borrowings to $848M.
DXP Q3 2025 sales $513.7M (+8.6% YoY); GAAP EPS $1.31; three acquisitions closed
Revenue $513.7M, up 8.6% YoY; GAAP diluted EPS $1.31; Adjusted EBITDA $56.5M.
DXP reports Q2 FY25 sales of $498.7M, up 11.9% YoY; GAAP EPS $1.43
Sales $498.7M, up 4.6% sequential and 11.9% year-over-year; GAAP diluted EPS $1.43.
DXP Enterprises expands ABL revolver by $50M to $185M to support acquisitions
ABL facility increased from $135M to $185M effective July 1, 2025.
DXP Q1 2025 sales $476.6M (+15.5% YoY); GAAP EPS $1.25; acquires Arroyo
Sales $476.6M, up 15.5% YoY; GAAP diluted EPS $1.25.
DXP Enterprises reports FY2024 sales $1.8B, up 7.4%; diluted EPS $4.22
Fiscal 2024 sales $1.8B, up 7.4% YoY; net income $70.5M vs $68.8M in FY2023.
DXP Q3 sales $472.9M (+12.8% YoY), GAAP EPS $1.27, Adj EBITDA $52.4M
Sales of $472.9 million, up 12.8% year-over-year and 6.1% sequentially.
DXP adds $105M term loan, cuts margin 100 bps, total borrowings $649.5M
Incremental $105M term loan brings total outstanding to $649.5M; matures Oct 13, 2030.
DXP Enterprises Q2 sales up 4.1% YoY to $445.6M; diluted EPS $1.00
GAAP diluted EPS of $1.00; Adjusted EBITDA of $48.2M.
DXP Enterprises Q1 2024: sales $412.6M, GAAP EPS $0.67, non-GAAP EPS $0.74
Sales of $412.6M; GAAP diluted EPS $0.67; non-GAAP diluted EPS $0.74.
DXP Enterprises reports fiscal 2023 sales up 13.4% to $1.7B, GAAP EPS $3.89
Fiscal 2023 sales $1.7B, up 13.4% YoY; net income $68.8M vs $48.2M.
DXP Enterprises Q3: EPS $0.93, up 31%; revenue $419.2M, up 8.2%
Diluted EPS $0.93, +31% YoY; revenue $419.2M, +8.2% YoY.
DXP refinances $550M term loan, raises incremental $125M at SOFR+4.75%, maturity 2030
Refinanced existing $425M TLB plus raised incremental $125M for total $550M; holds $107M cash on balance sheet.
DXP Q2 sales up 16.4% YoY to $428M; GAAP EPS $1.06
Sales $428.0M (+16.4% YoY); net income $19.0M vs $14.4M in Q2 2022.
DXP Q1 2023 sales up 32.8% YoY to $424.3M; net income rises to $17.6M
Sales $424.3M, up 32.8% year-over-year and 4.4% sequentially.
DXP Enterprises fiscal 2022 sales $1.5B (+32.9%), net income $48.2M, EPS $2.47
Fiscal 2022 sales rose 32.9% YoY to $1.5B, driven by acquisitions and organic growth.
DXP receives Nasdaq delisting notice for late 10-K; aims to file by April 12
Nasdaq notice received April 3, 2023, for non-compliance with Listing Rule 5250(c)(1) due to late 2022 10-K.
DXP Enterprises authorizes up to $85M or 2.8M share repurchase program
Board authorized repurchase of up to $85M or 2.8M shares in open market over 24 months.
DXP Enterprises closes $105M incremental Term Loan B, total outstanding $417.2M
Incremental $105M Senior Secured Term Loan B added to existing $330M TLB, total $417.2M outstanding.
DXP Q3 sales up 33.8% YoY to $387.3M; net income doubles to $13.9M
Sales $387.3M, up 33.8% YoY and 5.3% sequentially.
DXP Enterprises Q2 sales $367.8M (+28.7% YoY), net income $14.4M, EPS $0.74
Sales $367.8M, up 28.7% YoY and 15.2% sequentially.
DXP Q1 2022 sales up 30.1% YoY to $319.4M; GAAP EPS $0.65
$319.4M sales, up 30.1% year-over-year and 9.0% sequentially.
DXP replaces auditor with PwC; discloses new material weakness in revenue recognition
Appointed PwC as independent auditor for FY 2022, dismissing McConnell Jones after 2021 audit completes.
DXP fiscal 2021 sales $1.1B (+10.8% YoY); GAAP EPS $0.83, Adjusted EBITDA $70.2M
Fiscal 2021 sales of $1.1 billion, up 10.8% from fiscal 2020.
DXP Q3 2021 sales $289.5M (+31.5% YoY); GAAP EPS $0.36; closes two acquisitions
Revenue grew 31.5% year-over-year to $289.5 million, driven by organic growth and acquisitions.
DXP receives Nasdaq notice for late Q3 10-Q filing; delisting risk if not cured
Notice received Nov 16, 2021; 60 days to submit compliance plan by Jan 15, 2022.
DXP to replace audit firm immediately to complete 2021 audit on time
Company will immediately replace existing auditor to run review of Q3 10-Q and full year audit in parallel.
DXP auditor Moss Adams resigns; restatement; material weaknesses; Nasdaq compliance risk
Moss Adams resigned as auditor effective upon filing of Q3 10-Q; McConnell & Jones engaged for FY 2021.
DXP Enterprises to restate 2018-2020 annual and Q1 2021 financials; non-reliance advised
Restatement required for aged un-vouchered purchase orders in trade accounts payable and other immaterial items.
DXP restates financials; material weakness in internal controls over financial reporting discovered
Expects to reduce trade accounts payable by $8M-$12M and increase retained earnings by corresponding amount net of tax.
DXP Enterprises receives Nasdaq delinquency notice for late Q2 2021 10-Q filing
Received written notice from Nasdaq on August 17, 2021 for failure to timely file Form 10-Q for quarter ended June 30, 2021.
Sales $285.5 million, up 16.2% sequentially; GAAP diluted EPS $0.40.
On May 24, 2023, DXP Enterprises, Inc., (the “Company”) announced that David Molero has been appointed as DXP’s new Chief Accounting Officer, effective May 22, 2023.
Mr. Gene Padgett, the Chief Accounting Officer of DXP Enterprises, Inc. (the “Company”), informed the Company of his resignation from his position as Chief Accounting Officer of the Company effective October 10, 2022.
Mr. Kent Yee, the Company’s Chief Financial Officer and Senior Vice President Corporate Development will serve as principal accounting officer of the Company effective October 10, 2022 until further notice.
Also effective January 7, 2022, Paz Maestas was appointed Chief Marketing Officer and Chief Technology Officer.
DXP Enterprises is pleased to announce the appointment of Nick Little as Chief Operating Officer, effective January 7, 2022.
On October 28, 2021, the Board of Directors (the “Board”) of DXP Enterprises, Inc. (the “Company”) elected Mrs. Karen Hoffman as a director on the Board, effective October 29, 2021.
Max materiality 0.85 · Median 0.70 · Most common event earnings